Ownership history in RP Management, LLC · 15 quarters on record
This page tracks every 13F SEC filing in which RP Management, LLC reported a position in BIOCRYST PHARMACEUTICALS INC (BCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | UNCHANGED | 3,846,154 | — | 0% | 20.78% | $28.8M | $8.96 |
| 2025 Q1 | UNCHANGED | 3,846,154 | — | 0% | 20.78% | $28.8M | $7.50 |
| 2024 Q4 | UNCHANGED | 3,846,154 | — | 0% | 12.84% | $29.2M | $7.52 |
| 2024 Q3 | UNCHANGED | 3,846,154 | — | 0% | 12.84% | $29.2M | $7.60 |
| 2024 Q2 | UNCHANGED | 3,846,154 | — | 0% | 13.29% | $23.8M | $6.18 |
| 2024 Q1 | UNCHANGED | 3,846,154 | — | 0% | 10.85% | $19.5M | $5.08 |
| 2023 Q4 | UNCHANGED | 3,846,154 | — | 0% | 15.49% | $23.0M | $5.99 |
| 2023 Q3 | UNCHANGED | 3,846,154 | — | 0% | 26.28% | $27.2M | $7.08 |
| 2023 Q2 | UNCHANGED | 3,846,154 | — | 0% | 27.82% | $27.1M | $7.04 |
| 2023 Q1 | UNCHANGED | 3,846,154 | — | 0% | 44.43% | $32.1M | $8.34 |
As of 2025 Q4 — sorted by position size